EP4058025A1 — Pharmaceutical compositions comprising ticagrelor
Assigned to Santa Farma Ilac Sanayi AS · Expires 2022-09-21 · 4y expired
What this patent protects
The present invention relates to a pharmaceutical composition, comprising ticagrelor, wherein the pharmaceutical composition is manufactured by using wet granulation method improved flow character and compressibility properties wherein; the composition comprises microcrystalline …
USPTO Abstract
The present invention relates to a pharmaceutical composition, comprising ticagrelor, wherein the pharmaceutical composition is manufactured by using wet granulation method improved flow character and compressibility properties wherein; the composition comprises microcrystalline cellulose, and silicon dioxide together in the extragranular phase and dibasic calcium phosphate in intragranular phase with optimized lubrication time range between 6 to 12 minutes.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.